Delivra Health Brands Stock Price To Book
| DHBUF Stock | USD 0.01 0 10.24% |
Delivra Health Brands fundamentals help investors to digest information that contributes to Delivra Health's financial success or failures. It also enables traders to predict the movement of Delivra OTC Stock. The fundamental analysis module provides a way to measure Delivra Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Delivra Health otc stock.
Delivra |
Delivra Health Brands OTC Stock Price To Book Analysis
Delivra Health's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Delivra Health Price To Book | 1.66 X |
Most of Delivra Health's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Delivra Health Brands is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, Delivra Health Brands has a Price To Book of 1.6636 times. This is 93.52% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The price to book for all United States stocks is 82.51% higher than that of the company.
Delivra Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Delivra Health's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Delivra Health could also be used in its relative valuation, which is a method of valuing Delivra Health by comparing valuation metrics of similar companies.Delivra Health is currently under evaluation in price to book category among its peers.
Delivra Fundamentals
| Return On Equity | -1.01 | |||
| Return On Asset | -0.22 | |||
| Profit Margin | (0.77) % | |||
| Operating Margin | (0.66) % | |||
| Current Valuation | 4.15 M | |||
| Shares Outstanding | 252.62 M | |||
| Shares Owned By Insiders | 21.99 % | |||
| Price To Book | 1.66 X | |||
| Price To Sales | 0.48 X | |||
| Revenue | 8.14 M | |||
| Gross Profit | 2.6 M | |||
| EBITDA | (4.25 M) | |||
| Net Income | (7.01 M) | |||
| Cash And Equivalents | 1.67 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 1.67 M | |||
| Debt To Equity | 0.38 % | |||
| Current Ratio | 1.02 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (4.44 M) | |||
| Beta | 1.78 | |||
| Market Capitalization | 3.71 M | |||
| Total Asset | 11.59 M | |||
| Z Score | 1.2 | |||
| Net Asset | 11.59 M |
About Delivra Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Delivra Health Brands's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Delivra Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Delivra Health Brands based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Delivra OTC Stock
Delivra Health financial ratios help investors to determine whether Delivra OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Delivra with respect to the benefits of owning Delivra Health security.